Brian Nichols is the co-founder of Angel Squad, a community where you’ll learn how to angel invest and get a chance to invest as little as $1k into Hustle Fund's top performing early-stage startups

Key takeaways

• Shield AI raised a $1.5 billion Series G in March 2026 at a $12.7 billion valuation and $153.68 per share, led by Advent International, up 124% from its early-2025 round.
• Secondary units trade near $168.17, roughly 9% above the last round price and up about 102% over twelve months, with supply slightly exceeding demand.
• The Notice report shows a $1.6 billion 2025 revenue figure, but that is a linear projection. The company's actual revenue for the year ending March 2025 was about $300 million.
• On the real number, Shield AI trades closer to 46x revenue, not the 3.8x the headline implies. Big difference.
• Shield AI allows direct stock transfers, which is a genuine plus, but most small-check access still runs through SPVs, so the usual structural risks still apply.

Shield AI is one of the most talked-about names in defense tech, and the secondary market has been paying up. Units that traded near $83 last summer now sit around $168. The company builds autonomy software for uncrewed aircraft, its Hivemind stack flies drones and jets in places where GPS and comms get jammed, and demand for that capability is not exactly slowing down.

So the story is easy to like. The price is where it gets interesting, and where a little arithmetic saves you from a bad assumption. Let's actually run the numbers, because the headline ones are misleading in a way that matters.

What the Numbers Actually Say

Entry price versus the last round. The March 2026 Series G priced shares at $153.68 and set a $12.7 billion valuation. Secondary units trade near $168.17, about 9% above that. That is a modest premium by pre-IPO standards, and the reason is telling: Notice reports investor demand actually sitting slightly below the supply of available shares, at roughly 0.9 to 1. So the market is not fighting to get in here. The Series G itself was a big step up, 124% above the $5.3 billion valuation from February 2025, so a lot of the enthusiasm may already be priced.

The revenue trap. Here is the part that trips people up. The data report lists 2025 revenue of $1.6 billion, which would put the company at a cheap-looking 3.8x sales. Read the footnote. That figure is a projection built by assuming linear revenue growth, not a reported result. The company's actual revenue for the fiscal year ending March 2025 was about $300 million, per its own disclosures. It had been targeting $400 million and came up $100 million short. So the real trailing multiple is not 3.8x. Against a $13.9 billion market cap and $300 million in revenue, you are paying closer to 46x. That is a very different investment, and it is the single most important number in this whole analysis. If you take one thing from our work on why multiples drive your outcome, let it be the habit of checking whether a revenue figure is real or modeled before you anchor to it.

Forward multiple. The company is guiding to 70% to 100% annual growth on its way to a $1 billion revenue target for the year ending March 2028. If it hits somewhere near $550 million this fiscal year, the forward multiple lands around 25x. If it actually reaches $1 billion by 2028, today's price works out to roughly 14x on that year. Those are the numbers the bull case leans on, and they are not crazy for a fast-growing defense software business. The catch is the word "if," and the fact that the company already missed its most recent target by 25% is a reason to underwrite the growth conservatively.

Peer comparison. Set Shield AI's roughly 46x trailing revenue next to Stripe, a profitable fintech trading around 22x on the secondary, and the contrast is stark. You are paying more than double the multiple for a company one-twentieth the size that has not shown profitability and just missed a revenue goal. That can absolutely still work out, because defense autonomy is a real and growing market with a genuine deep tech moat. But you are underwriting execution at a rich price, not buying a bargain.

Revenue trajectory and profitability. The direction is strong. Revenue roughly doubled from 2022 into 2023 to about $163 million, then grew to around $300 million by early 2025. The government contract base is sticky and the Ukraine deployments have been a proving ground. Profitability, though, is undisclosed and almost certainly not there yet, because scaling defense hardware and integrating uncrewed systems burns cash. Treat the margin picture as a question mark and size accordingly.

The Demand Signal Is Quiet, Which Is Its Own Message

A 0.9-to-1 demand-to-supply ratio means there are marginally more sellers than buyers right now. That is unusual for a hot defense name, and it is worth sitting with. It could mean early holders are taking profits after a 124% markup. It could mean buyers are balking at the multiple once they do the real revenue math. Either way, the soft demand is why the secondary trades only 9% above the primary rather than at the big premiums you see on names where everyone is scrambling for allocation.

This is exactly the frame our very own Hustle Fund GP, Elizabeth Yin, uses on pricing. As she puts it, valuations come down to supply and demand: the supply of a tranche of shares against the demand from investors chasing it. When supply nudges ahead of demand, price stops climbing, and that is what the tape is showing here. Read the quiet as information, not noise.

The Hype Question

Defense AI is a hyped sector, full stop. Elizabeth's test for any company riding a wave is whether it is genuinely "10x different and 10x better" than the alternatives, not just wearing the trend as a costume. Shield AI has a real claim. Hivemind is autonomy that works when the network does not, which is the hard part, and it is embedded in platforms that militaries do not swap out casually. That is a durable wedge.

The bear case is that defense procurement is lumpy and slow, competition from both primes and other venture-backed entrants is intensifying, and a missed revenue target suggests the ramp is harder than the deck says. Both things are true at once. At 46x, the burden of proof sits with the growth.

How You Would Actually Buy It (And Why That Matters)

Good news first: Shield AI allows direct stock transfers, so it is possible to end up actually on the cap table rather than holding a derivative of a derivative. That is a meaningful advantage over names that ban transfers. That said, most accredited investors writing normal-sized checks will still come in through a special purpose vehicle pooled by a syndicate, because a single share block is large and lightly traded. So two risks still deserve your attention, and our SPV strategy guide covers the mechanics if you are newer to how these pool capital.

Risk one: forward purchase contracts are synthetic exposure. Even when direct transfers are allowed, some sellers offer a forward instead of actual shares. A forward is a contract in which the holder promises to deliver shares or their value to you later, usually at an exit. You are not on the cap table. You hold a promise. If the seller defaults, or the transfer gets blocked, or the seller's own arrangement collapses, you become an unsecured creditor of a counterparty rather than an owner of Shield AI. Given that a defense IPO could be years out, that counterparty risk rides along for a long time. Confirm you are buying actual shares, and if it is a forward, know exactly who stands behind it.

Risk two: second and third-layer SPVs stack fees and hide your cost basis. In syndicated deals, the vehicle you are offered is often not the one holding the stock. It is an SPV that bought into another SPV that holds the position. Each layer adds a management fee and a slice of carry, and each layer makes your true entry price murkier. On a name already trading at 46x, an extra couple of layers of fees can quietly push your effective multiple even higher without you seeing it. Ask how many layers separate your check from the shares and what each charges. Apply the same scrutiny you would to protective terms on an early-stage round, because the fee drag here is real.

The Bottom Line

Shield AI is a genuinely important company in a market that is not going anywhere, and the technology moat is real. The problem is not the company. It is that the secondary is asking roughly 46x actual revenue for a business that just missed its own target, with demand soft enough that the price is barely above the last round. That is a bet on flawless execution at a full price, which is a fine bet to make with your eyes open and a bad one to stumble into because a data screen said 3.8x.

This is precisely the kind of deal where catching the difference between modeled revenue and real revenue is worth more than any hot tip, and where the structuring details decide how much of your upside survives. That is a big part of why Angel Squad exists. It is a community of more than 2,500 investors across 50-plus countries who have collectively put over $30 million into 70-plus startups, with a strict no-a-holes policy and access to the top 1% of deal flow. Hustle Fund is an early-stage fund, but Squad members see the full spectrum, from pre-seed through pre-IPO names like this one, with the context to actually vet the numbers and the structure before wiring. Learn more at hustlefund.vc/squad.

Frequently Asked Questions

What is Shield AI's current valuation? Shield AI was valued at $12.7 billion in its March 2026 Series G, up 124% from its early-2025 round. On the secondary market, Notice puts its real-time market cap near $13.89 billion as of early June 2026.

What is Shield AI's secondary share price? Secondary units trade near $168.17 as of early June 2026, about 9% above the $153.68 Series G price. That is an algorithmic consensus from secondary activity and reference data, not a guaranteed execution price.

How much revenue does Shield AI actually generate? About $300 million for the fiscal year ending March 2025, per the company's own figures, up from roughly $163 million in 2023. Some data reports show a $1.6 billion figure, but that is a linear projection rather than a reported result.

Is Shield AI profitable? Shield AI does not disclose profitability, and scaling defense hardware and autonomy systems is capital-intensive, so it is very unlikely to be profitable today. Treat margins as undisclosed.

Can I buy Shield AI stock directly? Shield AI permits direct stock transfers, which is unusual and helpful. In practice, most accredited investors still access it through a special purpose vehicle, which carries fees and structural considerations worth checking.

When will Shield AI IPO? There is no confirmed timeline. Any secondary purchase should be underwritten as a multi-year, illiquid hold, with the growth ramp treated conservatively given the recent revenue miss.